Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.

Grade Last Price % Change $ Change
grade D $4.24 0.95% 0.04
ACHN closed up 0.95 percent on Thursday, February 23, 2017, on 78 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Down
See historical ACHN trend table...

Date Alert Name Type % Chg
Feb 23 Crossed Above 50 DMA Bullish 0.00%
Feb 23 Calm After Storm Range Contraction 0.00%
Feb 22 Fell Below 50 DMA Bearish 0.95%
Feb 21 Calm After Storm Range Contraction -2.53%
Feb 17 50 DMA Support Bullish -0.70%
Feb 17 Doji - Bullish? Reversal -0.70%
Feb 17 Calm After Storm Range Contraction -0.70%
Feb 16 50 DMA Support Bullish -0.70%
Feb 16 Wide Range Bar Range Expansion -0.70%
Feb 16 Bearish Engulfing Bearish -0.70%

Older signals for ACHN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Profile
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The company’s drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Is ACHN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.06
52 Week Low 3.78
Average Volume 1,468,609
200-Day Moving Average 6.77
50-Day Moving Average 4.22
20-Day Moving Average 4.27
10-Day Moving Average 4.34
Average True Range 0.2
ADX 14.34
+DI 20.9
-DI: 20.52
Chandelier Exit (Long, 3 ATRs) 4.14
Chandelier Exit (Short, 3 ATRs) 4.53
Upper Bollinger Band 4.58
Lower Bollinger Band 3.96
Percent B (%b) 0.45
Bandwidth 0.145199